Digital Therapeutics2019-08-05T10:28:17+00:00

Digital Therapeutics

Digital Therapeutics requires a new kind of CRO

Digital Therapeutics development challenges traditional processes and demands CRO experience and adaptability in order to navigate regulation, help design studies efficiently, and capture quality data to accelerate development.

Biorasi is the only forward-thinking CRO that already has the foundation in place for delivering successful Digital Therapeutics trials

Fully Technology Enabled

Talosᵀᴹ is our state of the art clinical research management platform that powers our clinical trials and ensures quality data capture and real time analysis

Accelerated Recruitment

Unleash the potential of partnerships with advocacy groups and national registries, and our global site network to quickly access difficult to target patient populations and meet your recruitment goals

Regulatory Expertise

Avoid delays and uncertainty by partnering with a CRO that knows how to navigate the novel regulatory environment for DTx, both in the US and around the world

Biorasi is a proven pioneering partner in Digital Therapeutics research
that can make groundbreaking therapies a reality

Therapeutic Area Mix

Digital Therapeutics trials entail a plethora of innovative logistics to efficiently treat, manage or even prevent a wide spectrum of physical, mental and behavioral conditions.

  • Patient-centric approach to trial execution that includes training and education

  • State of the art technology enabled clinical research management platform

  • Cutting-edge data sciences team that is a crucial part for navigating trial progress
  • Experienced medical and scientific affairs team creating protocol design and clinical development plan
  • Seasoned regulatory staff providing valuable support for software, device and device-drug based therapeutics

Biorasi is currently working
on multiple Digital Therapeutics
clinical trials in these areas:

We’re ready to answer your questions on digital therapeutics

Schedule a Call

Disrupting Industry Standards

Biorasi optimizes every step of clinical trials, cutting industry timelines by up to 70%

Protocol Finalized to First SSV

Biorasi

Industry Standard

5 days
14 days

SSV to SIV

Biorasi

Industry Standard

28 days
90 days

SIV to First Subject In

Biorasi

Industry Standard

5 days
21 days

Last Subject Out to Database Lock

Biorasi

Industry Standard

15 days
45 days

Database Lock to Top Line Results

Biorasi

Industry Standard

3 days
14 days

TOTAL TIME SAVINGS 70% SAVINGS

Biorasi

Industry Standard

54 days
184 days

Related Resources

FSGS: A rare kidney disease without targeted therapies

Researchers are studying a few new and existing drugs to treat FSGS. FSGS needs a novel medication that regulates both high body fats and inflammasome inhibition via upstream innate immune system to block intracellular initiation of inflammatory cascade and extra cellular inflammation. Over the past five years, nearly 30% of Biorasi-initiated or ongoing studies involved chronic kidney disease. Our experience allows us to develop successful nephrology clinical trials.

Is targeted gene therapy in Neurology’s future?

To unlock more targeted, effective treatments, genetics researchers are exploring mutations responsible for some of the most common motor neuron diseases. These discoveries may lead to gene therapy treatment routes that do a better job of slowing disease progression than current medications. Much like gene therapy in oncology has brought improvement in cancer regression in recent years, we believe gene therapy—particularly therapy that targets and modulates RNA—is the future of neurology.

Biorasi Center of Excellence Spotlight: Oncology

Biorasi’s Oncology Center of Excellence remains at the forefront of this exciting field. Our team of clinicians, program managers and other experts stay up to date on the latest developments, from Tumor Infiltrating Lymphocyte (TIL) therapy to gene therapy advances. This experience, combined with Biorasi’s worldwide site network and data-driven approach, allows us to guide oncology programs to success—on time and on budget.

Download our Precision Medicine Checklist

Complete the form below to receive a link to download this checklist
close-link

Schedule a call with one of our experts today

Let us know how we can help. Complete the form below and we will schedule a call
close-link

Start your FREE Trial Rescue Assessment!

Complete the form below and we will provide our free trial rescue assessment.
close-link

Download our Patient-Centric Trials White Paper

Complete the form below to receive a link to download this white paper
close-link

Download our Data Science White Paper

Complete the form below to receive a link to download this white paper
close-link

Schedule a TALOS™ Control Center Demo

Complete the form below to schedule a demo with our program development team
close-link

Download our Rare Disease Checklist

Complete the form below to receive a link to download this checklist
close-link

Download our Dermatology White Paper

Complete the form below to receive a link to download this white paper
close-link

Get Access to "Making Most of Trial Data" Webinar

Complete the form below to receive a link to access this webinar
close-link

Download our Precision Oncology White Paper

Complete the form below to receive a link to download this whitepaper
close-link